154 related articles for article (PubMed ID: 22236187)
1. Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel.
Giussani P; Bassi R; Anelli V; Brioschi L; De Zen F; Riccitelli E; Caroli M; Campanella R; Gaini SM; Viani P; Riboni L
Cancer Invest; 2012 Jan; 30(1):27-37. PubMed ID: 22236187
[TBL] [Abstract][Full Text] [Related]
2. Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway.
Gramatzki D; Herrmann C; Happold C; Becker KA; Gulbins E; Weller M; Tabatabai G
PLoS One; 2013; 8(5):e63527. PubMed ID: 23667632
[TBL] [Abstract][Full Text] [Related]
3. A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy.
Noack J; Choi J; Richter K; Kopp-Schneider A; Régnier-Vigouroux A
Cell Death Dis; 2014 Sep; 5(9):e1425. PubMed ID: 25255218
[TBL] [Abstract][Full Text] [Related]
4. Biliverdin reductase plays a crucial role in hypoxia-induced chemoresistance in human glioblastoma.
Kim SS; Seong S; Lim SH; Kim SY
Biochem Biophys Res Commun; 2013 Nov; 440(4):658-63. PubMed ID: 24113378
[TBL] [Abstract][Full Text] [Related]
5. Autophagy, the Trojan horse to combat glioblastomas.
Lefranc F; Kiss R
Neurosurg Focus; 2006 Apr; 20(4):E7. PubMed ID: 16709038
[TBL] [Abstract][Full Text] [Related]
6. Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells.
Daniele S; Pietrobono D; Costa B; Giustiniano M; La Pietra V; Giacomelli C; La Regina G; Silvestri R; Taliani S; Trincavelli ML; Da Settimo F; Novellino E; Martini C; Marinelli L
ACS Chem Neurosci; 2018 Jan; 9(1):85-99. PubMed ID: 28368610
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275.
Bangert A; Häcker S; Cristofanon S; Debatin KM; Fulda S
Anticancer Drugs; 2011 Jul; 22(6):494-9. PubMed ID: 21566522
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Kartal Yandım M; Apohan E; Baran Y
Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
[TBL] [Abstract][Full Text] [Related]
9. [The sodium pump could constitute a new target to combat glioblastomas].
Lefranc F; Mijatovic T; Kiss R
Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR.
Aoyama Y; Sobue S; Mizutani N; Inoue C; Kawamoto Y; Nishizawa Y; Ichihara M; Kyogashima M; Suzuki M; Nozawa Y; Murate T
Biochem Biophys Res Commun; 2017 Apr; 486(2):551-557. PubMed ID: 28322796
[TBL] [Abstract][Full Text] [Related]
11. Ceramide glycosylation potentiates cellular multidrug resistance.
Liu YY; Han TY; Giuliano AE; Cabot MC
FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390
[TBL] [Abstract][Full Text] [Related]
12. TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells.
Tian T; Li A; Lu H; Luo R; Zhang M; Li Z
Biochem Biophys Res Commun; 2015 Aug; 463(4):638-43. PubMed ID: 26043698
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alkylating agents on human glioblastoma cells.
Pédeboscq S; L'Azou B; Passagne I; De Giorgi F; Ichas F; Pometan JP; Cambar J
J Exp Ther Oncol; 2008; 7(2):99-111. PubMed ID: 18771084
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
[TBL] [Abstract][Full Text] [Related]
15. BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide.
Chen CM; Syu JP; Way TD; Huang LJ; Kuo SC; Lin CT; Lin CL
Int J Mol Med; 2015 Nov; 36(5):1244-52. PubMed ID: 26329365
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway.
Huang H; Lin H; Zhang X; Li J
Oncol Rep; 2012 Jun; 27(6):2050-6. PubMed ID: 22426504
[TBL] [Abstract][Full Text] [Related]
17. Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.
Benedetti E; Antonosante A; d'Angelo M; Cristiano L; Galzio R; Destouches D; Florio TM; Dhez AC; Astarita C; Cinque B; Fidoamore A; Rosati F; Cifone MG; Ippoliti R; Giordano A; Courty J; Cimini A
Oncotarget; 2015 Dec; 6(39):42091-104. PubMed ID: 26540346
[TBL] [Abstract][Full Text] [Related]
18. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas.
Lefranc F; Facchini V; Kiss R
Oncologist; 2007 Dec; 12(12):1395-403. PubMed ID: 18165616
[TBL] [Abstract][Full Text] [Related]
19. Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response.
Lee D; Sun S; Ho AS; Kiang KM; Zhang XQ; Xu FF; Leung GK
Anticancer Res; 2014 Jun; 34(6):2957-66. PubMed ID: 24922660
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis.
Shi L; Zhang S; Feng K; Wu F; Wan Y; Wang Z; Zhang J; Wang Y; Yan W; Fu Z; You Y
Int J Oncol; 2012 Jan; 40(1):119-29. PubMed ID: 21879257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
